Cargando…
A brief review concerning Chimeric Antigen Receptors T cell therapy
The understanding concerning the function of immune system in cancer has achieved considerable advance with time passes by. Manipulating genetically engineered immune cells were investigated as a novel strategy for treating cancer. Chimeric antigen receptors (CARs) are recombinant protein molecules...
Autores principales: | Li, Ling-Lin, Yuan, Hong-Ling, Yang, Yu-Qiong, Wang, Lin, Zou, Ren-Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391193/ https://www.ncbi.nlm.nih.gov/pubmed/32742489 http://dx.doi.org/10.7150/jca.46308 |
Ejemplares similares
-
Chimeric antigen receptor T-cell therapy for T-ALL and AML
por: Wei, Wenwen, et al.
Publicado: (2022) -
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
por: Khurana, Arushi, et al.
Publicado: (2022) -
Chimeric antigen receptor T-cell therapy
por: Burge, Cale, et al.
Publicado: (2023) -
Chimeric antigen receptor T cell therapies for multiple myeloma
por: Wu, Chao, et al.
Publicado: (2019) -
Chimeric Antigen Receptor T-Cell Therapy: The Light of Day for Osteosarcoma
por: Lin, Zili, et al.
Publicado: (2021)